Klaria Pharma Holding AB (STU:6FN) Total Stockholders Equity : €0.29 Mil (As of Dec. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Klaria Pharma Holding AB Total Stockholders Equity?

Klaria Pharma Holding AB's Total Stockholders Equity for the quarter that ended in Dec. 2024 was €0.29 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Klaria Pharma Holding AB's Book Value per Share for the quarter that ended in Dec. 2024 was €0.00. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Klaria Pharma Holding AB's Debt-to-Equity for the quarter that ended in Dec. 2024 was 6.99.

Klaria Pharma Holding AB Total Stockholders Equity Historical Data

The historical data trend for Klaria Pharma Holding AB's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Klaria Pharma Holding AB Total Stockholders Equity Chart

Klaria Pharma Holding AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Stockholders Equity

Get a 7-Day Free Trial

10.77

6.76

6.92

3.68

0.29

Klaria Pharma Holding AB Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Total Stockholders Equity	Get a 7-Day Free Trial															3.68	2.58	1.84	1.14	0.29

Klaria Pharma Holding AB (STU:6FN) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Klaria Pharma Holding AB's Book Value per Share for the quarter that ended in Dec. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(0.287	-	0)	/	144.759
	=	0.00

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Klaria Pharma Holding AB's Debt-to-Equity for the quarter that ended in Dec. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(1.952	+	0.054)	/	0.287
	=	6.99

Klaria Pharma Holding AB Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Klaria Pharma Holding AB's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Klaria Pharma Holding AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Klaria Pharma Holding AB (STU:6FN) » Definitions » Total Stockholders Equity

Traded in Other Exchanges

KLAR:Sweden

Address

Virdings Alle 2, Uppsala, SWE, 754 50

Website

https://www.klaria.com

Klaria Pharma Holding AB is engaged in the development and commercialization of pharmaceutical products in Sweden for migraine and cancer-related pain. Its operations are based on a patented drug delivery platform in the form of an alginate-based polymer film. Majority of the group's operations are conducted in Sweden.

Klaria Pharma Holding AB Headlines

No Headlines